GAM Holding’s Dr. Reddy's Laboratories RDY Stock Holding History

GAM Holding’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-72,000	Closed	-$1.08M	–	304
2025 Q2	$1.08M	Buy	+72,000	New	+$1.03M	0.08%	187
2024 Q1	–	Sell	-230,000	Closed	-$3.2M	–	184
2023 Q4	$3.2M	Hold	230,000	–	–	0.24%	108
2023 Q3	$3.08M	Hold	230,000	–	–	0.23%	107
2023 Q2	$2.9M	Sell	230,000 -60,000	-21%	-$700K	0.2%	113
2023 Q1	$3.3M	Buy	290,000 +50,000	+21%	+$540K	0.23%	117
2022 Q4	$2.48M	Hold	240,000	–	–	0.2%	121
2022 Q3	$2.51M	Buy	+240,000	New	+$2.56M	0.19%	118
2022 Q1	–	Sell	-186,265	Closed	-$2.44M	–	328
2021 Q4	$2.44M	Hold	186,265	–	–	0.11%	160
2021 Q3	$2.43M	Buy	186,265 +90,270	+94%	+$1.2M	0.11%	168
2021 Q2	$1.41M	Hold	95,995	–	–	0.06%	208
2021 Q1	$1.18M	Sell	95,995 -149,245	-61%	-$1.92M	0.05%	231
2020 Q4	$3.5M	Sell	245,240 -80	-0%	-$1.08K	0.21%	132
2020 Q3	$3.41M	Buy	245,320 +39,735	+19%	+$474K	0.21%	154
2020 Q2	$2.18M	Buy	205,585 +25,585	+14%	+$260K	0.14%	192
2020 Q1	$1.45M	Buy	+180,000	New	+$1.5M	0.1%	212
2019 Q4	–	Sell	-71,115	Closed	-$539K	–	744
2019 Q3	$539K	Hold	71,115	–	–	0.02%	558
2019 Q2	$533K	Sell	71,115 -350,000	-83%	-$2.75M	0.02%	664
2019 Q1	$3.41M	Hold	421,115	–	–	0.14%	164
2018 Q4	$3.17M	Buy	421,115 +125,000	+42%	+$879K	0.16%	149
2018 Q3	$2.05M	Buy	296,115 +225,000	+316%	+$1.5M	0.07%	284
2018 Q2	$458K	Hold	71,115	–	–	0.02%	685
2018 Q1	$465K	Hold	71,115	–	–	0.02%	644
2017 Q4	$534K	Hold	71,115	–	–	0.02%	728
2017 Q3	$507K	Sell	71,115 -401,000	-85%	-$2.88M	0.02%	429
2017 Q2	$3.98M	Buy	472,115 +51,115	+12%	+$416K	0.06%	375
2017 Q1	$3.38M	Buy	421,000 +50,000	+13%	+$432K	0.05%	403
2016 Q4	$3.36M	Sell	371,000 -74,000	-17%	-$689K	0.06%	369
2016 Q3	$4.13M	Buy	445,000 +2,500	+0.6%	+$23.9K	0.07%	298
2016 Q2	$4.53M	Sell	442,500 -602,500	-58%	-$5.52M	0.07%	321
2016 Q1	$9.45M	Buy	1,045,000 +429,000	+70%	+$3.83M	0.16%	161
2015 Q4	$5.7M	Buy	616,000 +377,000	+158%	+$4.13M	0.09%	237
2015 Q3	$3.06M	Buy	239,000 +7,500	+3%	+$93.2K	0.05%	361
2015 Q2	$2.56M	Sell	231,500 -23,750	-9%	-$262K	0.04%	464
2015 Q1	$2.92M	Sell	255,250 -21,250	-8%	-$225K	0.04%	411
2014 Q4	$2.79M	Buy	276,500 +109,500	+66%	+$1.15M	0.04%	419
2014 Q3	$1.75M	Buy	167,000 +95,000	+132%	+$893K	0.03%	543
2014 Q2	$621K	Buy	72,000 +42,500	+144%	+$357K	0.01%	797
2014 Q1	$259K	Buy	+29,500	New	+$257K	﹤0.01%	876
2013 Q4	–	Sell	-42,500	Closed	-$321K	–	1015
2013 Q3	$321K	Buy	+42,500	New	+$309K	0.01%	874

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Holding's RDY Position: Q3 2025 in Review

GAM Holding sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 72,000 shares — an estimated $1.08M sold.

GAM Holding first reported a position in RDY in Q3 2013 and held it in 39 quarters. The position peaked at $9.45M in Q1 2016. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

GAM Holding reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
GAM Holding sold 72,000 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $1.08M.
GAM Holding first reported a position in Dr. Reddy's Laboratories in Q3 2013 and held it in 39 quarters.
GAM Holding's Dr. Reddy's Laboratories position peaked at $9.45M in Q1 2016.
228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on GAM Holding's 13F filing for Q3 2025, filed 21 Oct 2025.